Abstract Osteoporosis and fractures occur frequently in patients with b-thalassemias, a group of congenital hemolytic anemias characterized by decreased synthesis of the b chain of hemoglobin. In this study, we determined the bone abnormalities of the th3 thalassemia mouse, generated by deletion of the mouse b-chain genes. The heterozygous th3/ ? mouse has moderate anemia and serves as a model of b-thalassemia intermedia, which represents the mild thalassemia phenotype. The th3/th3 mouse has lethal anemia and is a model of b-thalassemia major, which is characterized by life-threatening anemia requiring regular transfusions to sustain life. Compared to controls, (1) lCT of trabecular bone showed decreased bone volume fraction, number of trabeculae, and trabecular thickness in both th3/? and th3/th3 (P \ 0.05); (2) cortical bone analysis showed thinner cortices and increased marrow area in th3/? (P \ 0.05); (3) lCT abnormalities in th3/? mice were present by 2 months and did not worsen with age; (4) histomorphometry was significant for decreased bone formation and resorption in both th3/? and th3/th3, and expression of cathepsin K and osteocalcin from bone of both th3/? and th3/th3 animals was reduced (P \ 0.05); (5) biomechanics showed reduced maximum load, maximum moment, and structural stiffness in both th3/? and th3/th3 (P \ 0.01). In conclusion, the th3 mouse model of thalassemia manifests bone changes reminiscent of those in humans and can be used for further bone studies in thalassemia. Bone changes are associated with decreased bone turnover and develop early during the period of bone accrual.
concentrations beginning early in life. In addition, iron overload, chelation, and endocrine dysfunction secondary to iron overload have all been implicated in the development of low bone mass. However, recent studies in humans have yet to identify with certainty the exact role of each of these factors [7] .
Studies on the bone disease of thalassemia using a mouse model have not yet been performed. The recent development of the thalassemia mouse (th3) can provide a tool for the study of this disease [8] . This mouse was generated by deletion of both mouse b-globin genes, b1 and b2, located on chromosome 7 of the C57/BL6 mouse [8] . In this study, we sought to characterize the bone abnormalities that occur in the th3 thalassemia mouse. From these results and further manipulation of this model, we hope to shed light on the etiology of low bone mass in thalassemia as a prelude to developing more effective therapies.
In humans, the most severe form of homozygous b-thalassemia, called b-thalassemia major (TM) or Cooley anemia, is characterized by a life-threatening anemia, which results in death if not treated by chronic transfusions [1] . A less severe phenotype, b-thalassemia intermedia (TI), is associated with mild to moderate anemia that does not require regular transfusions [1] . The heterozygous th3 mouse (th3/?) exhibits a phenotype comparable to human TI, which is characterized by moderate anemia. The homozygous th3 mouse (th3/th3) dies late in gestation because the switch from fetal to adult Hb production is completed between gestational days 14 and 16, while in humans the switch occurs in early childhood. An adult mouse model of TM was generated by engrafting wild-type (WT) C57/BL6 mice with b-globin-null (th3/th3) fetal liver cells [8] . This engrafted mouse, referred to here as ''th3/ th3,'' manifests a lethal red cell hemolysis approximately 2 months posttransplant. It was used in this study to investigate the bone changes characteristic of TM.
Materials and Methods

Animals
th3/? mice were generously provided by the laboratory of one of the authors (S. R.). Engrafted th3/th3 mice were generated as previously described [8] . Two-month-old WT C57/BL6 recipient mice were irradiated (IR) with 9 Gy (single dose) and transplanted with donor th3/th3 fetal liver cells on the day of irradiation. Donor fetal liver cells were harvested at embryonic day 14.5 from embryos obtained by intercrossing th3/? mice. The genotype of the embryos was determined by analyzing their Hb by cellulose acetate electrophoresis. A second group of 2-month-old C57/BL6 mice was irradiated and transplanted with fetal liver cells from WT embryos and served as IR controls for experiments involving th3/th3 mice. All studies were approved by the Institutional Animal Care and Use Committees of Weill Cornell Medical College.
Experimental Design and Procedures
Characterization of the Bone Phenotype of the Thalassemia Mouse
To determine the bone abnormalities of the th3/th3 mouse, we studied its changes compared to IR and WT controls. th3/th3 and IR animals were generated as described above at age 2 months. They were killed 2 months posttransplantation, at age 4 months. The WT control group consisted of sex-matched C57/BL6 mice, also killed at age 4 months (n = 6/group, 3M/3F). To characterize the th3/? mouse, we studied its bone abnormalities compared to ageand sex-matched C57/BL6 controls (n = 6/group, 3M/3F) at age 4 months.
The vertebrae and right femur from each animal were cleaned of soft tissue, stored in 90% ethanol, and scanned by micro-computed tomography (lCT) as detailed below. After lCT analysis, the femurs were subjected to biomechanical testing as described below. For dynamic histomorphometry, mice were injected with calcein (100 mg/kg body weight) and xylenol orange (90 mg/kg body weight), respectively, at 7 and 3 days prior to death. The left femur was fixed in graded ethanols and embedded in methylmethacrylate (MMA). Longitudinal nondecalcified femur sections (5 lm) were cut on an HM360 microtome (Microm, Walldorf, Germany) and used for histomorphometry, as detailed below. Additional longitudinal nondecalcified sections (2 lm) were mounted on barium fluoride (BaF 2 ) infrared windows (Spectral Systems, Hopewell Junction, NY) for Fourier transform infrared spectroscopic imaging (FTIRI) analyses. One femur from a second set of th3 and th3/th3 animals (n = 6/group) was fixed in 10% buffered formalin at 4°C, dehydrated in progressive concentrations of ethanol, cleared in xylene, and embedded in paraffin. Five-micron-thick sections were cut, deparaffinized, and stained for tartrate-resistant acid phosphatase (TRAP). The other femur was cleaned, the tips were cut, and bone marrow was removed. The remaining bone was used for mRNA extraction as described below. The liver and spleen were collected for measurement of tissue iron content.
Longitudinal Studies of the th3/? Mouse
To determine if the bone abnormalities in this mouse model of thalassemia worsen with age, we performed longitudinal lCT studies of the th3/? mouse. th3/? mice and age-matched C57/BL6 controls (n = 6/group, 3 M/3F) were also studied at 2, 6, and 9 months of age. Similar studies could not be performed with the th3/th3 mouse because it dies of anemia 2 months after transplantation. The vertebrae and right femur from each animal were cleaned of soft tissue, stored in 90% ethanol, and scanned by lCT as detailed below. The liver and spleen were removed for measurement of tissue iron content.
Hb and Tissue Iron Content
Hb measurements were made using the HemoCue Hemoglobin System (HemoCue, Lake Forest, CA) prior to death. Spleen and liver iron content was determined by atomic absorption spectroscopy. Whole-organ weight was determined and a representative sample placed in a tarred porcelain crucible. After determining the wet weight of the sample, the crucible was placed in a drying oven (110°C) overnight. The dry weight of the sample was determined, after which it was ashed in a Muffle furnace at 550°C. The ash was dissolved in 3 N HCl and its Fe content determined by atomic absorption.
lCT
Densitometric and morphometric lCT analysis was performed on cortical bone from mid-diaphyses of femurs and trabecular bone from distal femurs and L5 vertebrae. Bones were scanned in their entirety by two different lCT scanners. The Enhanced Vision Systems (GE Healthcare, London, Canada) model MS08 was used on mice aged 2 and 4 months and model MS09, on those aged 6 and 9 months. An isotropic 12 9 12 9 12 lm voxel size was used in bone scans of 2-and 4-month-old mice and a 15 9 15 9 15 lm voxel size was used in scans of 6-and 9-month-old mice. In all scans, 80 KVp, 80 lA, and a 4°r otation step were used. Reconstruction of 3D volumes from the 2D projections into CT volume data was performed using Beam software (GE Healthcare) with a modified Parker algorithm. Densitometric analysis of the 3D volumes was performed using microView software (GE Healthcare). For morphometric analysis, Scanco (Bassersdorf, Switzerland) software was used.
Cortical and trabecular regions of interest (ROIs) were first defined on the volumes of whole bones using a utility of the microView software. In the femurs, the trabecular ROIs extended from 50 lm proximally to the end of the distal growth plate over 1.7 mm toward the diaphysis. The whole trabecular bone was included for analysis in vertebral bodies. Trabecular ROIs were drawn freehand on sequential slices to include the endosteal envelope, conforming to the endosteal contour on each slice. Cortical ROIs were defined as 1.7-mm segments of the middiaphysis of femurs. A global threshold was defined as the lowest mineral density, from all bones analyzed, for which volumes were noise-free and trabeculae appeared to have the same width in binarized images as in the gray-scale image. Bone mineral density (BMD) measurements were performed on cortical and trabecular volumes after segmentation of bone voxels using the global threshold, to include only bone tissue. For cortical and trabecular morphometric measurements, the volumes were binarized using the same threshold as in the BMD measurements. They were then exported as DICOM files for processing by the Scanco software. Morphometric variables of cortical bone regions included bone area and thickness, inner and outer perimeters, marrow area, maximum cross-sectional moment of inertia (I max ), and minimum cross-sectional moment of inertia (I min ). The morphometric parameters defining trabecular bone, directly measured in 3D, included bone volume fraction (BV/TV), trabecular thickness (Tb.Th), trabecular number (Tb.N), and trabecular spacing (Tb.Sp).
Fourier Transformed Infrared Imaging Spectroscopy
Three sections of proximal femur from each animal were examined by FTIRI using the Perkin-Elmer (Shelton, CT) Spotlight 3.0 Imaging system. Cortical and trabecular bones were examined separately. The spectral resolution was either 4 or 8 cm -1 , while the spatial resolution was *7 lm. Spectra were transformed to yield images corresponding to infrared band areas, peak height ratios, and integrated area ratios by a combination of the spectrometer software and ISYS Chemical Imaging Software (v 2.1; Spectral Dimensions, Olney, MD). Background spectra were collected under identical conditions from the same BaF 2 windows.
Three spectroscopic parameters were calculated: mineral-to-matrix ratio (Min/Matrix), carbonate-to-mineral ratio (Carb/Min), and collagen cross-link ratio. The Min/Matrix ratio is the integrated areas ratio of the PO 4 band (900-1,200 cm -1 ) to the amide I band (1,590-1,720 cm -1 ) and a measure that corresponds to ash weight [9] . The Carb/Min ratio (carbonate band 840-890 cm -1 / PO 4 band 900-1,200 cm -1 ) indicates carbonate substitutions in hydroxyapatite [10] . The collagen cross-link ratio is a parameter reflecting the relative ratio of nonreducible and reducible collagen cross-links, expressed as the absorbance ratio at two specific wavelengths (1,660 and 1,690 cm -1 ) [11] . In the spectral images, pixels devoid of bone (no mineral and/or matrix spectral signature) were set to zero and masked so as to be excluded from the calculations. The spectroscopic results were expressed as histograms describing the pixel distribution of the parameters above, resulting in three cortical and three cancellous bone parameters for each bone. The mean for each animal's cortical and trabecular bone was calculated, along with characteristics of the pixel distributions generated at the same time using ISYS software. Means were averaged for multiple sites in each animal and among the six different animals for each age and genotype using Microsoft (Redmond, WA) Excel.
Bone Histomorphometry
Longitudinal femoral sections were stained using the von Kossa method and Goldner's trichrome. Bone measurements were performed in cancellous bone tissue of the proximal metaphysis beginning 1 mm from the central region of the growth plate to exclude the primary spongiosa and 500 lm from the endocortical margins to exclude modeling bone. The Bioquant (Nashville, TN) program Bioquant-True Color Windows (sVGA Frame Grabber Image Processing Board and Optronics DEI-470 Video Camera) was used to collect the raw data. Trabecular BV/ TV (%), osteoclast surface, and osteoid surface for bone surface (BS) were measured. Paraffin-embedded longitudinal tibial sections were stained for TRAP using a commercially available kit (Sigma, St. Louis, MO). Osteoclasts were identified as TRAP-positive cells on the bone surface. Osteoclast number per BS (n/mm) was then determined using the same Bioquant program.
Fluorochrome-based indices of bone formation were measured in unstained 5-lm longitudinal sections of distal femur. Double-and single-labeled perimeters were identified. Interlabel widths of double-labeled regions were measured using the Bioquant program. The mineral apposition rate (MAR, lm/day) and bone formation rate (BFR/ BS, lm 3 /lm 2 /day) were then determined.
Biomechanical Testing
Structural mechanical behavior was measured via threepoint bending to failure. The femur, with the anterior aspect facing up, was placed horizontally on two supports with a span width of 7.0 mm. A central load was applied on the anterior surface of the mid-diaphysis midway between the supports at a displacement rate of 0.05 mm/second using an ElectroForce 3200 system (Bose, Eden Prairie, MN) until the bone fractured. Maximum load, structural stiffness, and maximum moment were determined from the resulting load-displacement curve. Structural stiffness was calculated as the slope of the linear ascending portion of the curve.
Quantitative RT-PCR mRNA from femurs of th3/? and th3/th3 animals and their controls was extracted after bone marrow was removed. 0 -CGTGATTCAAATCCCTGAAGT-3 0 ), were purchased from Invitrogen. All of the primer pairs used amplified a single band with the expected molecular weight as analyzed by agarose gel electrophoresis. The quantities of all samples were normalized to the mouse HPRT housekeeping gene.
Statistical Analysis
Results are presented as means ± SD. The differences between th3/? mice and age-matched WT controls were evaluated by Student's t-test. The differences between th3/th3 mice, IR controls, and WT controls were evaluated by oneway analysis of variance. Because of the small sample size, we were unable to assess the effect of sex on the observed parameters. However, initial comparisons to sex-and agematched controls consistently confirmed the observations in each group of animals. Statistical analysis was performed using STATA software (StataCorp, College Station, TX). Differences with P \ 0.05 were considered significant.
Results
Bone Abnormalities of th3/? and th3/th3 Mice At age 4 months, the th3/? mouse demonstrated moderate anemia (mean Hb 7.7 ± 0.6 g/dl in th3/? compared to 12.3 ± 1.3 g/dl in WT, P \ 0.01). th3/th3 mice were studied at age 4 months (2 months after transplantation), and results were compared to 4-month WT and IR controls (2 months after transplantation). As expected, the mean Hb of th3/th3 mice was extremely low, 1.1 ± 0.4 g/dl, compared to 11.3 ± 1.5 g/dl in IR mice and 12.5 ± 2.0 g/dl in WT (P \ 0.001).
Liver and spleen iron content were increased in th3/? mice compared to WT (liver 1.8 ± 0.14 vs. 0.35 ± 0.04 lg/ mg/dry weight, th3/? vs. WT, mean ± SD, P \ 0.001;
WT, P \ 0.001). Liver iron content was also increased in the th3/th3 mouse (4.4 ± 0.4 lg/mg/dry weight) compared to IR (0.3 ± 0.02 lg/mg dry weight) and WT (0.36 ± 0.04 lg/ mg dry weight) (P \ 0.001). However, spleen iron content of th3/th3 mice was the same as controls (3.95 ± 1.2 vs. 3.5 ± 1.5 vs. 4.4 ± 1.5 lg/mg/dry weight, th3/th3 vs. IR vs. WT). These results suggest differences in tissue iron distribution between th3/? and th3/th3 mice.
lCT analysis identified similar trabecular abnormalities in both thalassemia mice (Table 1) . These included decreased BV/TV, Tb.N, and Tb.Th in both th3/? and th3/ th3 compared to their respective controls. Irradiation was found to have an intermediate effect on trabecular bone, with the lCT values of IR animals plotting between the values seen in WT and th3/th3 mice. However, trabecular changes in th3/th3 mice remained significantly different from those in IR animals.
Analysis of cortical bone (mid-diaphysis femur) in the th3/? mouse showed decreased cortical thickness and cortical area and increased marrow area and inner perimeter compared to controls (Table 1) . Cortical bone analysis of the th3/th3 mouse did not differ from WT or IR controls. This is not surprising as this mouse was generated at age 2 months, when a great part of bone growth and accrual had been accomplished.
Changes in bone composition and material properties were determined by FTIRI. The spectroscopic parameters measured were Min/Matrix and Carb/Min ratios and collagen cross-links. No difference was found in the mean values of these FTIR parameters between thalassemic mice and controls. Typical images of cortical sections and their respective pixel histograms for the th3/? mouse at age 4 months are presented in Fig. 1 . Although, we did not detect statistically significant changes in the mean values of either cortical or cancellous bone FTIRI, we saw qualitative differences in pixel distribution histograms between affected and control animals, with the widths of the distribution increased in thalassemic mice.
Biomechanical properties were tested by three-point bending. Femurs of th3/? and th3/th3 mice showed decreased maximum load, maximum moment, and stiffness compared to their controls, indicating increased fragility (Table 2 ). Similar to our lCT results, irradiation was found to have an effect on biomechanical properties, with values plotting between those of WT and th3/th3 animals.
Histomorphometry showed decreased MAR and BFR in both th3/? and th3/th3 mice compared to controls. In addition, we found decreased BV/TV (%), decreased osteoid surface (% BS), and decreased octeoclast number for BS (n/mm) in both thalassemia mice (Fig. 2) . These results indicate decreased bone formation and resorption in these animals. Similar to histomorphometric results, RT-PCR analysis of femur-extracted mRNA of both th3/? and th3/th3 mice and their respective controls was significant for decreased expression of CTK and OC (P \ 0.01, Fig. 3 ), indicating again decreased bone turnover. Of note, both histomorphometry and RT-PCR data support an increase in bone turnover in IR animals compared to nonirradiated WT controls.
Longitudinal Studies of the th3/? Mouse
To determine longitudinal changes in thalassemia, we performed lCT analysis of trabecular and cortical bone of the th3/? mouse and age-and sex-matched controls at ages Values are expressed as mean ± SD * P \ 0.01; ** P \ 0.05, P = trend 2, 4, 6, and 9 months. The percent change in lCT parameters of the th3/? mouse compared to controls was calculated at each time point and presented in Fig. 4 as percent of baseline. We found that lCT abnormalities are present by age 2 months and do not worsen by 9 months of age. Data on Hb concentrations and liver and spleen iron content in these animals at various time points are shown in Table 3 . The severity of anemia remained the same over the 9-month period, while tissue iron content appeared to plateau after 4 months. Values are expressed as mean ± SD * P \ 0.01 Fig. 2 Histomorphometry indicates decreased bone formation and resorption in both th3/? and th3/th3 mice compared to their controls. Calcein (100 mg/kg body weight) and xylenol orange (90 mg/kg body weight) were injected at 7 and 3 days, respectively, prior to death. Double-and single-labeled perimeters and interlabel width of double-labeled regions were measured. The mineral apposition rate (MAR, lm/day) and bone formation rate (BFR/ BS, lm 3 /lm 2 /day) were then determined. Longitudinal femur sections were also stained using the von Kossa method and Goldner's trichrome. Trabecular bone volume (BV/TV, %), osteoclast surface, and osteoid surface for bone surface (BS) were measured. Paraffinembedded longitudinal femur sections were stained for TRAP. Osteoclast number per BS (n/ mm) was then determined. All measurements were done using the Bioquant program. WT wildtype, shown as white bars; IR irradiated control, shown as gray-patterned bars; th3/? shown as gray bars; th3/th3 shown as black bars. * P \ 0.05
Discussion
In this study, we determined the bone abnormalities of th3 and th3/th3 thalassemia mice. The th3/? mouse has mild-to-moderate anemia and splenomegaly and, thus, represents a model of TI. The th3/th3 model has lethal hemolysis comparable to TM. Both th3/? and th3/th3 mice had similar trabecular abnormalities, characterized by a decreased number of trabeculae and increased trabecular spacing. Cortical bone abnormalities were present only in the th3/? mouse and were significant for an increased bone marrow area and thinner cortices. Both models had changes in biomechanical properties suggestive of increased fragility. Overall, the bone abnormalities of the th3 thalassemia mouse were reminiscent of the changes that have been traditionally described in patients with the disease.
We must acknowledge that, besides differences in the severity of hemolysis, there are additional characteristics that distinguish th3/? and th3/th3 mice. These features may influence the bone phenotype as well as affect the use of these models in further studies of bone disease in thalassemia. th3/th3 animals are generated via transplantation of WT mice at an age when normal bone development has been largely achieved. They die of anemia in the relatively short period of 8-10 weeks, which may affect the severity of the bone abnormalities that we observe. Their short lifespan does not allow for easy manipulation of the model or therapeutic interventions. It is likely, therefore, that the absence of cortical bone abnormalities in the th3/th3 mouse is related to model limitations rather than to thalassemia itself. The assessment of bone changes in the th3/th3 mouse is further complicated by the effect of total-body irradiation on the bone. To account for this limitation, the results of the th3/th3 mouse were compared to both WT and IR controls. Irradiation had a detectable effect on trabecular lCT values. Nonetheless, the lCT results in th3/th3 mice were significant even when compared to IR controls. There was also a trend toward decreased biomechanical properties in irradiated controls, suggesting that the results of biomechanical testing in th3/th3 animals can be attributed in part to irradiation. On the other hand, the th3/? mouse has none of the above limitations and has a normal life span, so we can easily use it for longitudinal and other intervention studies. Finally, because of the small number of studied animals, we are unable to comment on potential gender differences in these animal models. It also possible that the effect of irradiation on the bone was missed because of the small sample size.
FTIRI analysis was performed to determine changes in the material composition of the bone, including mineralization relative to the collagen composition of the bone, hydroxyapatite structure, and collagen maturity. Mean values in FTIRI parameters did not differ between the thalassemia mice and their controls. It is possible that the study was underpowered to detect small FTIR changes. However, we observed differences in the distribution of measured parameters among animal groups, which suggest differences in heterogeneity of the various chemical components that constitute a healthy bone structure [12, 13] . Bone is heterogeneous due to constant remodeling and differences in the rates of primary and secondary mineralization. Heterogeneity is thought to affect the mechanical properties of bone [14] . Decreased heterogeneity in FTIR parameters, e.g., has been observed with prolonged bisphosphonate treatment, which may contribute to the increased bone brittleness that has been described with such therapy [13] .
Based on the longitudinal th3/? lCT data, the bone abnormalities are established by 2 months. There is no evidence of progressive bone loss by 9 months. This is similar to what has been recently reported in patients with the disease. Specifically, peak bone mass is suboptimal in patients with thalassemia, and loss of bone mass is more pronounced in children and adolescents compared to adults, indicating a primary problem with bone accrual [7] .
Thalassemia is characterized by anemia and ineffective erythropoiesis, or otherwise, the production and subsequent destruction of large numbers of defective red blood cells and their precursors in the bone marrow [1] . Ineffective Fig. 3 Decreased cathepsin K and osteocalcin expression in both th3/ ? and th3/th3 mice compared to controls. Total mRNA was prepared from femurs after bone marrow was flushed. Levels of expression were normalized to the mouse HPRT housekeeping gene. Values are expressed as mean ± SD. WT wild-type, shown as white bars; IR irradiated control, shown as gray-patterned bars; th3/? shown as gray bars; th3/th3 shown as black bars. * P \ 0.05, ** P \ 0.01 erythropoiesis has been associated with the development of facial and long bone deformities in TM patients chronically maintained at low Hb levels [15] . These abnormalities resolve with regular transfusions that start early in life [15] , confirming the role of ineffective erythropoiesis in such cases. However, the impact of ineffective erythropoiesis in the development of low bone mass despite the near normalization of Hb concentrations is unclear. Our data indicate that the ineffective erythropoiesis associated with mild to moderate anemia, such as that seen in the th3/? mouse, is sufficient to cause changes in bone microarchitecture and material properties and is associated with decreased bone turnover. Decreased bone turnover was indeed found in both th3/? and th3/th3 mice. In addition to ineffective erythropoiesis, both mice have evidence of increased liver iron content. This is most likely related to Fig. 4 Longitudinal lCT analysis of th3/? mice. a lCT analysis of trabecular (first row) and cortical (second row) bone. Percent increase or decrease of various lCT parameters of th3/? animals compared to age-matched controls was calculated. Animals were studied at ages 2, 4, 6, and 9 months (n = 6/group). lCT changes were present by 2 months and did not worsen by 9 months. Error bars represent SDs. b Representative lCT images of th3/? animals and their controls at 2 and 9 months: vertical sections of vertebral body at L5 (first row) and cortical bone at mid-diaphysis femur (second row). Affected animals manifest thinning of trabeculae and thinner cortices. Comparison of images at 2 and 9 months does not indicate progressive disease, indicating that these bone abnormalities develop early during the period of bone accrual increased gastrointestinal absorption of iron. As has been recently shown, hepcidin, a negative regulator of intestinal iron absorption, is inappropriately suppressed in this model, leading to increased iron absorption [16] . However, the iron overload that is seen typically in patients is much more severe and related primarily to repeated transfusions. Although we cannot rule out the fact that the degree of increased tissue iron that is found in the thalassemia mouse may be responsible for some of its bone abnormalities, the predominant pathologic process in these animals is ineffective erythropoiesis.
Bone turnover has been examined in adult patients with TM maintained on regular transfusions and iron chelation therapy. Contrary to our animal data, these patients have been described as having mildly increased resorption [17, 18] . The effect of iron chelation on bone metabolism is largely unknown and may contribute to the increased resorption in humans. Most adults with TM have ironinduced hypogonadism [19] , which is known to be associated with increased resorption. Finally, differences in bone turnover between humans and other animals may have to do with differences in the severity of iron overload. The role of iron excess in the development of osteoporosis in patients with thalassemia or hereditary hemochromatosis, a disease caused by mutations that increase intestinal iron absorption, has yet to be confirmed because studies in humans yield inconsistent results [7, 20] . Moreover, the role of iron overload in bone turnover is still unclear, with a single report documenting focal osteomalacia due to iron in poorly transfused and iron-overloaded patients [21] .
In summary, this study of mouse models of TI and TM documents changes in bone microarchitecture and increased fragility analogous to what is seen in patients with the disease and validates their use in further studies on osteoporosis in thalassemia. As in humans, the bone abnormalities present early in life indicate a defect in bone accrual. Both bone formation and resorption are decreased in these mice. Further studies are needed to document the role of iron in bone microarchitecture and remodeling, and to bring to light the factors that lead to the decreased bone turnover associated with ineffective erythropoiesis.
